CN103316296B - Traditional Chinese medicine composition for treating hyperostosis - Google Patents
Traditional Chinese medicine composition for treating hyperostosis Download PDFInfo
- Publication number
- CN103316296B CN103316296B CN201310252324.XA CN201310252324A CN103316296B CN 103316296 B CN103316296 B CN 103316296B CN 201310252324 A CN201310252324 A CN 201310252324A CN 103316296 B CN103316296 B CN 103316296B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating hyperostosis. The traditional Chinese medicine composition is prepared from the traditional Chinese medicine materials in parts by weight: 10-30 parts of astragalus membranaceus, 10-30 parts of angelica sinensis, 10-40 parts of suberect spatholobus stem, 5-20 parts of large-leaved gentian, 10-40 parts of root of red-rooted salvia, 10-30 parts of ligusticum wallichii, 5-20 parts of flowers carthami, 5-20 parts of eupolyphaga, 5-20 parts of pberetima, 5-20 parts of radix angelicae pubescentis, 10-40 parts of parasitic loranthus, 5-10 parts of asarum, 5-20 parts of frankincense, 5-20 parts of myrrh, 5-20 parts of radix curcumae longae, 10-40 parts of pawpaw, 10-40 parts of radix paeoniae alba, 5-20 parts of medicinal cyathula root, 5-20 parts of lycopodium clavatum, 5-15 parts of scorpio, 5-15 parts of centipede, 5-20 parts of gastrodia elata, 5-15 parts of garter snake, and 5-20 parts of liquorice. The traditional Chinese medicine composition disclosed by the invention has the effects of tonifying liver and kidney, enriching and activating blood, removing blood stasis to stimulate menstrual flow, clearing damp and dispersing blood stasis, and stimulating the circulation of the blood and activating collaterals, and is significant in treatment effect on the hyperostosis, and reliable in effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical product not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of hyperosteogeny.
Background technology
Hyperosteogeny is also called hyperplastic osteoarthritis, osteoarthritis, degenerative joint disease, senile arthritis, hypertrophiarthritis, soft tissue degeneration, the degeneration such as cartilage, intervertebral disc, ligament owing to forming joint, joint margins forms the change such as bony spur, synovial membrane plumpness, and there is osteoclasia, cause insecondary hyperosteogeny, cause joint deformity, when being subject to abnormal load, cause arthralgia, a kind of disease of the symptoms such as limitation of activity.The method of current treatment hyperosteogeny has two kinds: one, western medicine, the principle of western medicine hyperosteogeny is all antiinflammatory, pain relieving, its common medicine is non-steroid class anti-inflammation analgesic, as ibuprofen, ketoprofen, ibuprofen etc., that is, just temporarily alleviate a little misery, the cause of disease also exists, Relapse rate after drug withdrawal, and Long-term taking medicine toxic and side effects is large, impairing the liver kidney.Two, operative treatment, operative treatment is that hypertrophy position is removed, and painful large, patient not easily accepts.
The traditional Chinese medical science is thought, hyperosteogeny (bony spur) disease belongs to " arthromyodynia " category of the traditional Chinese medical science, also known as " rheumatism involving the bone ".Hyperosteogeny is relevant with wound, strain, obstruction of collaterals by blood stasis, the damp that is affected by the cold, phlegm resistance, caused by liver and kidney deficiency etc.
According to theory of Chinese medical science, for the pathogeny of hyperosteogeny, with blood circulation promoting and blood stasis dispelling, migratory arthralgia dredging collateral, liver and kidney tonifying for the rule for the treatment of, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
There is the large deficiency of side effect to overcome in prior art, the invention provides a kind of prepare easy, cost is low, evident in efficacy, the Chinese medicine composition for the treatment of hyperosteogeny that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of hyperosteogeny, it is characterized in that: its raw material of Chinese medicine and weight are: Radix Astragali 10-30 part, Radix Angelicae Sinensis 10-30 part, Caulis Spatholobi 10-40 part, Radix Gentianae Macrophyllae 5-20 part, Radix Salviae Miltiorrhizae 10-40 part, Rhizoma Chuanxiong 10-30 part, Flos Carthami 5-20 part, eupolyphaga 5-20 part, Pheretima 5-20 part, Radix Angelicae Pubescentis 5-20 part, Herba Taxilli 10-40 part, Herba Asari 5-10 part, Olibanum 5-20 part, Myrrha 5-20 part, Rhizoma Curcumae Longae 5-20 part, Fructus Chaenomelis 10-40 part, Radix Paeoniae Alba 10-40 part, Radix Cyathulae 5-20 part, Herba Lycopodii 5-20 part, Scorpio 5-15 part, Scolopendra 5-15 part, Rhizoma Gastrodiae 5-20 part, Zaocys 5-15 part, Radix Glycyrrhizae 5-20 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of hyperosteogeny, is characterized in that: its raw material of Chinese medicine and weight are: the Radix Astragali 20 parts, Radix Angelicae Sinensis 20 parts, Caulis Spatholobi 30 parts, Radix Gentianae Macrophyllae 10 parts, Radix Salviae Miltiorrhizae 30 parts, Rhizoma Chuanxiong 20 parts, 10 parts, Flos Carthami, eupolyphaga 10 parts, Pheretima 12 parts, Radix Angelicae Pubescentis 10 parts, Herba Taxilli 30 parts, Herba Asari 6 parts, Olibanum 10 parts, Myrrha 10 parts, 10 parts, Rhizoma Curcumae Longae, Fructus Chaenomelis 30 parts, the Radix Paeoniae Alba 30 parts, Radix Cyathulae 10 parts, Herba Lycopodii 12 parts, Scorpio 10 parts, Scolopendra 10 parts, 10 parts, Rhizoma Gastrodiae, Zaocys 10 parts, 15 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: the Radix Astragali has effect that benefiting QI for strengthening the superficies, arresting sweating are admittedly de-, hold in the palm skin ulcer granulation promoting, inducing diuresis to remove edema; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation; Caulis Spatholobi has to enrich blood invigorates blood circulation, relaxes through effect of dredging collateral; Radix Gentianae Macrophyllae has effect of Eradicates rheumatism, relaxing muscles and tendons network, clearind deficient heat; Radix Salviae Miltiorrhizae has effect of promoting blood flow to regulate menstruation, blood stasis dispelling eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Rhizoma Chuanxiong has effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; Flos Carthami has effect of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain; Eupolyphaga has effect of eliminating stasis to stop pain, reunion of fractured tendons and bones; Pheretima has effect of clearing heat for calming endogenous wind, lung-clearing asthma-relieving, inducing diuresis for treating stranguria syndrome, current meridians; Radix Angelicae Pubescentis has effect of expelling wind and dampness, dispersing cold for relieving pain; Herba Taxilli has effect of invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling, antiabortive unit; Herba Asari has the cold expelling that induces sweat, wind-expelling pain-stopping, warming the lung to resolve fluid-retention, sensible effect; Olibanum has effect of blood-activating and qi-promoting, inducing menstruation to relieve menalgia, detumescence and promoting granulation; Myrrha has effect of loose blood blood stasis removing, subduing swelling and relieving pain; Rhizoma Curcumae Longae has effect of removing blood stasis circulation of qi promoting, inducing menstruation to relieve menalgia; Fructus Chaenomelis has effect of suppressing the hyperactive liver relaxing muscles and tendons, stomach function regulating removing dampness; The Radix Paeoniae Alba has effect of nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing receipts antiperspirant; Radix Cyathulae has effect of eliminating blood stasis and inducing menstruation, easing joint movement, inducing diuresis for treating stranguria syndrome; Herba Lycopodii has effect of expelling wind and cold, dehumidifying detumescence, relaxing muscles and tendons and activating QI and blood in the collateral; Scorpio has endogenous wind stopping spasmolytic, dispersing pathogen accumulation, effect of removing obstruction in the collateral to relieve pain; Scolopendra has endogenous wind stopping spasmolytic, dispersing pathogen accumulation, effect of removing obstruction in the collateral to relieve pain; Rhizoma Gastrodiae has effect of endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral; Zaocys has effect of wind-damp dispelling, the meridian dredging; Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component through dialectical compatibility, help using mutually assistant, play the liver and the kidney tonifying altogether, enrich blood invigorate blood circulation, eliminating blood stasis and inducing menstruation, damp eliminating blood stasis dispelling, relaxing muscles and tendons and activating QI and blood in the collateral effect, treating both the principal and secondary aspects of a disease is reached to the treatment of hyperosteogeny.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and in drug component except Scorpio, Scolopendra are taken after mixing it with water for face, other drug adopts the use that is decocted in water for oral dose.Through clinical practice checking, it is reliably evident in efficacy, mild in medicine property and, do not occur toxic and side effects, effective percentage reaches 95%, cure rate 65%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for hyperosteogeny, its raw material of Chinese medicine and weight proportion are: Radix Astragali 20g, Radix Angelicae Sinensis 20g, Caulis Spatholobi 30g, Radix Gentianae Macrophyllae 10g, Radix Salviae Miltiorrhizae 30g, Rhizoma Chuanxiong 20g, Flos Carthami 10g, eupolyphaga 10g, Pheretima 12g, Radix Angelicae Pubescentis 10g, Herba Taxilli 30g, Herba Asari 6g, Olibanum 10g, Myrrha 10g, Rhizoma Curcumae Longae 10g, Fructus Chaenomelis 30g, Radix Paeoniae Alba 30g, Radix Cyathulae 10g, Herba Lycopodii 12g, Scorpio 10g(rush), Scolopendra 10g(rushes), Rhizoma Gastrodiae 10g, Zaocys 10g, Radix Glycyrrhizae 15g.
Embodiment 2
Treat a Chinese medicine composition for hyperosteogeny, its raw material of Chinese medicine and weight proportion are: Radix Astragali 10g, Radix Angelicae Sinensis 30g, Caulis Spatholobi 20g, Radix Gentianae Macrophyllae 15g, Radix Salviae Miltiorrhizae 40g, Rhizoma Chuanxiong 30g, Flos Carthami 5g, eupolyphaga 15g, Pheretima 10g, Radix Angelicae Pubescentis 15g, Herba Taxilli 20g, Herba Asari 10g, Olibanum 15g, Myrrha 5g, Rhizoma Curcumae Longae 20g, Fructus Chaenomelis 20g, Radix Paeoniae Alba 25g, Radix Cyathulae 5g, Herba Lycopodii 10g, Scorpio 5g(rush), Scolopendra 15g(rushes), Rhizoma Gastrodiae 12g, Zaocys 15g, Radix Glycyrrhizae 10g.
Embodiment 3
Treat a Chinese medicine composition for hyperosteogeny, its raw material of Chinese medicine and weight proportion are: Radix Astragali 30g, Radix Angelicae Sinensis 10g, Caulis Spatholobi 15g, Radix Gentianae Macrophyllae 12g, Radix Salviae Miltiorrhizae 20g, Rhizoma Chuanxiong 10g, Flos Carthami 20g, eupolyphaga 12g, Pheretima 15g, Radix Angelicae Pubescentis 5g, Herba Taxilli 40g, Herba Asari 5g, Olibanum 20g, Myrrha 12g, Rhizoma Curcumae Longae 12g, Fructus Chaenomelis 40g, Radix Paeoniae Alba 10g, Radix Cyathulae 20g, Herba Lycopodii 5g, Scorpio 12g(rush), Scolopendra 8g(rushes), Rhizoma Gastrodiae 20g, Zaocys 5g, Radix Glycyrrhizae 12g.
Embodiment 4
Treat a Chinese medicine composition for hyperosteogeny, its raw material of Chinese medicine and weight proportion are: Radix Astragali 15g, Radix Angelicae Sinensis 25g, Caulis Spatholobi 40g, Radix Gentianae Macrophyllae 5g, Radix Salviae Miltiorrhizae 25g, Rhizoma Chuanxiong 25g, Flos Carthami 15g, eupolyphaga 5g, Pheretima 20g, Radix Angelicae Pubescentis 12g, Herba Taxilli 25g, Herba Asari 8g, Olibanum 12g, Myrrha 15g, Rhizoma Curcumae Longae 5g, Fructus Chaenomelis 35g, Radix Paeoniae Alba 20g, Radix Cyathulae 12g, Herba Lycopodii 15g, Scorpio 8g(rush), Scolopendra 5g(rushes), Rhizoma Gastrodiae 15g, Zaocys 12g, Radix Glycyrrhizae 20g.
Embodiment 5
Treat a Chinese medicine composition for hyperosteogeny, its raw material of Chinese medicine and weight proportion are: Radix Astragali 25g, Radix Angelicae Sinensis 15g, Caulis Spatholobi 10g, Radix Gentianae Macrophyllae 20g, Radix Salviae Miltiorrhizae 10g, Rhizoma Chuanxiong 15g, Flos Carthami 12g, eupolyphaga 20g, Pheretima 5g, Radix Angelicae Pubescentis 20g, Herba Taxilli 10g, Herba Asari 6g, Olibanum 5g, Myrrha 20g, Rhizoma Curcumae Longae 15g, Fructus Chaenomelis 10g, Radix Paeoniae Alba 40g, Radix Cyathulae 15g, Herba Lycopodii 20g, Scorpio 15g(rush), Scolopendra 12g(rushes), Rhizoma Gastrodiae 5g, Zaocys 8g, Radix Glycyrrhizae 5g.
In Chinese medicine composition in the embodiment of the present invention except Scorpio, Scolopendra are taken after mixing it with water for face, other drug decocting method routinely produces medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and covers powder, soaks 15 ~ 20 minutes, then adds water and do not have powder about 6 centimetres, carries out first time to decoct, and adopts intense fire to decoct, with slow fire boiling 20 ~ 30 minutes after boiling at a simmer; Second decocts, and adds water and does not have powder about 4 centimetres, decoct, and decocts 15 ~ 20 minutes after water boils.Decoct extracting juice twice, merge.
With a kind of Chinese medicine composition for the treatment of hyperosteogeny given by embodiment 1, do clinical efficacy and be summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation 80 cases, man 50 example, female 30 example, 45 ~ 65 years old age.
Two, diagnosis basis:
(1) primary multiple life was at about 50 years old, and Secondary cases mostly occurs at about 40 years old;
(2) pain during activity, pain relief or disappearance during inertia;
(3) function of joint is limited in various degree, has deformity in various degree late period;
(4) x-ray shows as joint space and narrows, joint margins lip sample hypertrophy, and hyperosteogeny is formed.Advanced joint cartilage obviously destroys, and joint space obviously narrows, joint deformity and subluxation.
Three, usage and dosage: during clinical practice, the amounts of components in compositions takes the circumstances into consideration increase and decrease according to the body weight of patient and age.Potion on the one, decocting twice extracting juice is about 300ml, point morning, late twice empty stomach decoction being taken warmly.It within five days, is a course for the treatment of.
Four, criterion of therapeutical effect:
(1) cure: patient's pain, swollen, picotement disappearance, joint motion is normal;
(2) effective: patient's pain, swollen, picotement obviously alleviate;
(3) effective: patient's pain, swollen, picotement alleviate to some extent;
(4) invalid; Sings and symptoms is all not improved, and symptom is as front.
Five, therapeutic effect: in this clinical observation case, takes medicine 3-10 the course for the treatment of, and recovery from illness 52 example, follows up a case by regular visits to and have no recurrence; Effective 14 examples, effective 10 examples, invalid 4 examples.There is not toxic and side effects in treatments period.
Six, model case:
Case 1: seat, female, 46 years old.Private prosecution time medical: the left gonalgia, difficulty in walking, activities adverse.Take the photograph sheet through x-ray to examine as left knee joint hyperosteogeny.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, pain subtracts greatly, can walk; Continue to take 3 courses for the treatment of, pain disappears, and cures.
Case 2: poplar, man, 62 years old.Two knee joint pain, difficulty in walking, X-ray examination knee joint hyperosteogeny.Take 4 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, pain relief; Continue to take 3 courses for the treatment of, pain disappears, and cures completely.Follow up a case by regular visits to after 1 year without recurrence.
Case 3: Chen, female, 58 years old.Suffer from the pain in the lumbar region several years, recently day by day exacerbate, can not change one's position and stand up, night, pain increased, and lie awake all night, such as the acupuncture of conscious back is seemingly lancinated, agony.X-ray inspection is examined as lumbar vertebra hyperosteogeny.Take pharmaceutical treatment prepared by Chinese medicine composition of the present invention and treat 4 courses for the treatment of, pain relief; Continue to take 3 courses for the treatment of, pain disappears, and freedom of movement, cures completely.
Claims (1)
1. treat a Chinese medicine composition for hyperosteogeny, it is characterized in that: its raw material of Chinese medicine and weight proportion are: Radix Astragali 20g, Radix Angelicae Sinensis 20g, Caulis Spatholobi 30g, Radix Gentianae Macrophyllae 10g, Radix Salviae Miltiorrhizae 30g, Rhizoma Chuanxiong 20g, Flos Carthami 10g, eupolyphaga 10g, Pheretima 12g, Radix Angelicae Pubescentis 10g, Herba Taxilli 30g, Herba Asari 6g, Olibanum 10g, Myrrha 10g, Rhizoma Curcumae Longae 10g, Fructus Chaenomelis 30g, Radix Paeoniae Alba 30g, Radix Cyathulae 10g, Herba Lycopodii 12g, Scorpio 10g, Scolopendra 10g, Rhizoma Gastrodiae 10g, Zaocys 10g, Radix Glycyrrhizae 15g; In the Chinese medicine composition of described treatment hyperosteogeny except Scorpio, Scolopendra are taken after mixing it with water for face, other drug decocting method routinely produces medicament.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310252324.XA CN103316296B (en) | 2013-06-24 | 2013-06-24 | Traditional Chinese medicine composition for treating hyperostosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310252324.XA CN103316296B (en) | 2013-06-24 | 2013-06-24 | Traditional Chinese medicine composition for treating hyperostosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103316296A CN103316296A (en) | 2013-09-25 |
| CN103316296B true CN103316296B (en) | 2015-03-04 |
Family
ID=49185529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310252324.XA Expired - Fee Related CN103316296B (en) | 2013-06-24 | 2013-06-24 | Traditional Chinese medicine composition for treating hyperostosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103316296B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104127633A (en) * | 2014-07-24 | 2014-11-05 | 黄武 | Traditional Chinese medicine composition extract for treating hyperosteogeny and preparation method thereof |
| CN105816605A (en) * | 2016-05-26 | 2016-08-03 | 张晓燕 | Traditional Chinese medicine composition for treating hyperostosis |
| CN105943764A (en) * | 2016-06-25 | 2016-09-21 | 丁常燕 | Traditional Chinese medicine composition for treating hyperostosis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1092066C (en) * | 1999-12-27 | 2002-10-09 | 王振宇 | Analgesic plaster for osteoarthritis |
| CN100450526C (en) * | 2006-10-25 | 2009-01-14 | 雒宏志 | Chinese medicinal formulation for treating rheumatic and rheumatoid disease |
-
2013
- 2013-06-24 CN CN201310252324.XA patent/CN103316296B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103316296A (en) | 2013-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100402066C (en) | Plaster for treating rheumatism and osteoarthrosis | |
| CN103393840B (en) | A kind of Chinese medicine composition for the treatment of osteoarthritis | |
| CN103463241B (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
| CN103006951A (en) | Chinese medicinal composition for treating cervical spondylosis and lumbar spondylosis | |
| CN103316295B (en) | Traditional Chinese composition for treating rheumatic arthritis | |
| CN103784887A (en) | Traditional Chinese medicinal composition for treating kidney deficiency lumbago | |
| CN103191383A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN103536777B (en) | Traditional Chinese medicinal composition for treating knee osteoarthritis | |
| CN103316298B (en) | Traditional Chinese composition for treating arthralgia | |
| CN103316141B (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN102048900A (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion | |
| CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN103028089B (en) | Traditional Chinese medicine composition for treating waist pains of middle-aged and old people | |
| CN102512560B (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
| CN104771489A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN104173564A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN104161917A (en) | Traditional Chinese medicine composition for treating caput femoris necrosis | |
| CN103169876B (en) | Chinese medicament composition for treating arthralgia | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN105796891A (en) | Traditional Chinese medicinal composition for treating epigastric pain | |
| CN104173934A (en) | Traditional Chinese medicine composition for treating sciatica | |
| CN104013765A (en) | Traditional Chinese medicine composition for treating deficiency of liver-yin and kidney-yin | |
| CN103191305A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
| CN105663612A (en) | Traditional Chinese medicine composition for treating ankylosing spondylitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: SUN YI Free format text: FORMER OWNER: LIU HUI Effective date: 20150130 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Sun Yi Inventor after: Liu Hui Inventor before: Liu Hui |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU HUI TO: SUN YI LIU HUI |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150130 Address after: 264300 Shandong city of Weihai province Rongcheng Chengshan Avenue East No. 101 Applicant after: Sun Yi Address before: 264300, No. 91, building No. 11, lotus pond North District, Weihai City, Shandong, Rongcheng Applicant before: Liu Hui |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150304 Termination date: 20150624 |
|
| EXPY | Termination of patent right or utility model |